FOCACCETTI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 862
EU - Europa 289
AS - Asia 145
AF - Africa 4
SA - Sud America 3
OC - Oceania 1
Totale 1.304
Nazione #
US - Stati Uniti d'America 854
IT - Italia 116
SG - Singapore 69
SE - Svezia 68
IN - India 42
DE - Germania 41
CN - Cina 28
FI - Finlandia 12
GB - Regno Unito 11
CA - Canada 7
FR - Francia 7
RO - Romania 7
UA - Ucraina 7
BE - Belgio 5
ID - Indonesia 5
RU - Federazione Russa 5
BG - Bulgaria 4
AR - Argentina 3
AL - Albania 2
IE - Irlanda 2
NL - Olanda 2
TG - Togo 2
EG - Egitto 1
MV - Maldive 1
MX - Messico 1
NZ - Nuova Zelanda 1
ZA - Sudafrica 1
Totale 1.304
Città #
Fairfield 145
Ashburn 102
Chandler 77
Rome 69
Woodbridge 60
Houston 56
Wilmington 49
Singapore 48
Ann Arbor 39
Seattle 38
Cambridge 31
Princeton 30
Santa Clara 25
Plano 18
Beijing 13
San Paolo di Civitate 13
Millbury 12
Dearborn 11
Lawrence 11
San Diego 7
Boston 6
Fremont 6
Milan 6
Toronto 6
Andover 5
Helsinki 5
Jakarta 5
Boardman 4
Grafing 4
New York 4
Norwalk 4
Sofia 4
Bremen 3
Brussels 3
Bühl 3
Federal 3
Nanjing 3
Redwood City 3
Washington 3
Dublin 2
Falls Church 2
Jacksonville 2
Lomé 2
Los Angeles 2
Phoenix 2
Potomac 2
Tirana 2
Waanrode 2
Amorosi 1
Cairo 1
Casal Di Principe 1
Caserta 1
Chengdu 1
Chongqing 1
Delhi 1
Des Moines 1
Falkenstein 1
Grosseto 1
Hamilton 1
Hebei 1
Jinan 1
Jönköping 1
Kunming 1
London 1
Male 1
Mariano Comense 1
Mexico City 1
Mumbai 1
Napoli 1
Ottawa 1
Oxford 1
Paris 1
Philadelphia 1
Prato 1
Provo 1
Redmond 1
Rieti 1
Sacramento 1
Shenyang 1
Silverton 1
Solan 1
State College 1
Varberg 1
Xian 1
Yellow Springs 1
Totale 989
Nome #
Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells 110
Combination of chemotherapy and PD-1 blockade induces T cell responses to tumor non-mutated neoantigens 105
Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer 86
Local delivery of recombinant vaccinia virus encoding for neu counteracts growth of mammary tumors more efficiently than systemic delivery in neu transgenic mice 84
Wnt3a neutralization enhances T-cell responses through indirect mechanisms and restrains tumor growth 83
Resveratrol and diallyl disulfide enhance curcumin-induced sarcoma cell apoptosis 76
CD8+ T cells specific for cryptic apoptosis-associated epitopes exacerbate experimental autoimmune encephalomyelitis 74
Resveratrol potentiates the in vitro and in vivo anti-tumoral effects of curcumin in head and neck carcinomas. 70
Fluoropyrimidine toxicity in patients with dihydropyrimidine dehydrogenase splice site variant: The need for further revision of dose and schedule 67
The Immunobiology of Cancer: From Tumor Escape to Cancer Immunoediting Towards Immunotherapy in Gynecologic Oncology 65
Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth 64
Fatty acid metabolism complements glycolysis in th selective regulatory t cell expansion during tumor growth 61
Effects of diet-derived molecules on the tumor microenvironment 59
The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer 58
Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors 56
Therapeutic implications of immunogenic cell death in human cancer 52
Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ros production in endothelial cells and cardiomyocytes 49
Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology 46
Immunogenicity comparison of interferon beta-1a preparations using the BALB/c mouse model: assessment of a new formulation for use in multiple sclerosis 30
Control of CD56 expression and tumor cell cytotoxicity in human Vγ2Vδ2 T cells 25
Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion 24
The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival 17
DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy 5
Totale 1.366
Categoria #
all - tutte 4.168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.168


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020235 0 0 0 0 32 39 45 34 34 23 16 12
2020/2021105 11 14 5 3 15 7 1 6 19 13 9 2
2021/2022222 0 14 24 9 29 13 9 27 16 12 35 34
2022/2023269 52 42 13 30 39 32 2 20 31 2 5 1
2023/2024141 1 13 4 19 12 25 12 11 3 10 11 20
2024/2025101 7 0 35 19 40 0 0 0 0 0 0 0
Totale 1.366